Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

57890 Results Found

Conducting assessments of electrical system risks

Discovering and protecting against external and internal power vulnerabilities

Equipment planning for imaging suites

Adopting future-proofing strategies to help secure the most advanced technology for renovation and new construction projects

The elements of an overall risk mitigation effort

Regular testing is just one part of a thorough risk assessment plan
Member

Daily Alert Report - August 28, 2023

Alerts published on August 28, 2023.

Kaufman Hall report highlights impact of continued decline in hospitals’ patient volumes, revenue

July saw the continued worsening of hospitals’ finances, according to a new Kaufman Hall report.

Federal court revives benefits denial class action suit against UHC subsidiary

A three-judge panel in federal court last week partially revived a class action lawsuit against UnitedHealth Group subsidiary United Behavioral Health, reversing an earlier decision from 2020.

AHA comments on CY 2024 home health proposed rule; expresses concern over net negative update

AHA responded to the Centers for Medicare & Medicaid Services’ calendar year 2024 proposed rule for the home health prospective payment system by voicing its extreme concern with the overall net negative update.

AHA supports CMS proposal to limit short-term, limited-duration plans

AHA Aug. 28 supported the Centers for Medicare & Medicaid Services’ proposal to change how certain forms of noncomprehensive coverage can be marketed and sold.

AHA supports bill offering providers gold card exemptions under Medicare Advantage

In an Aug. 28 letter to House sponsors, the AHA voiced support for the GOLD Card Act of 2023 (H.R. 4968) that would exempt qualifying providers from prior authorization requirements under Medicare Advantage plans.

Administration announces first Medicare drug negotiation list

The Department of Health and Human Services announced the first list of Medicare Part D drugs subject to price negotiations, a tenet of the Inflation Reduction Act designed to reduce health care costs.